CD44 and neoplasm: In summary, taken together these data indicate that upon binding to CD44+ tumor cells in vivo RG7356 triggers the secretion of chemo-attractants that are necessary for the recruitment of immune cells (i.e. macrophages) to the tumor site, finally leading to antibody-dependent cellular phagocytosis (ADCP) of the malignant cells by macrophages.